(HBM) Hudbay Minerals - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA4436281022
Stock: Copper, Zinc, Precious Metals
Total Rating 55
Risk 59
Buy Signal -0.67
| Risk 5d forecast | |
|---|---|
| Volatility | 64.9% |
| Relative Tail Risk | -6.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.72 |
| Alpha | 95.95 |
| Character TTM | |
|---|---|
| Beta | 1.994 |
| Beta Downside | 2.939 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.10% |
| CAGR/Max DD | 1.39 |
EPS (Earnings per Share)
Revenue
Description: HBM Hudbay Minerals March 05, 2026
Hudbay Minerals Inc. (HBM) is a diversified mining company established in 1927 and headquartered in Toronto, Canada. The company operates across North and South America.
HBMs business model involves the exploration, development, operation, and optimization of mining properties. This integrated approach is common in the mining sector to control the entire production lifecycle from resource identification to metal extraction.
The company produces and sells several metal concentrates and doré. These include copper concentrates (containing copper, gold, and silver), silver/gold doré, zinc concentrates (containing zinc and gold), and molybdenum concentrates. Diversified metal production can mitigate risks associated with price fluctuations of a single commodity.
For further in-depth analysis of Hudbay Minerals Inc., consider exploring ValueRays comprehensive data.
Headlines to watch out for
- Copper price fluctuations impact revenue significantly
- Gold and silver prices influence concentrate sales
- Zinc market volatility affects profitability
- Operating costs for mines dictate margins
- Regulatory changes in mining jurisdictions pose risks
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 570.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.39 > 1.0 |
| NWC/Revenue: -2.96% < 20% (prev 25.30%; Δ -28.25% < -1%) |
| CFO/TA 0.11 > 3% & CFO 686.0m > Net Income 570.5m |
| Net Debt (523.8m) to EBITDA (1.44b): 0.36 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (400.0m) vs 12m ago 1.52% < -2% |
| Gross Margin: 32.46% > 18% (prev 0.33%; Δ 3.21k% > 0.5%) |
| Asset Turnover: 37.87% > 50% (prev 36.83%; Δ 1.03% > 0%) |
| Interest Coverage Ratio: 13.44 > 6 (EBITDA TTM 1.44b / Interest Expense TTM 74.1m) |
Altman Z'' 2.45
| A: -0.01 (Total Current Assets 1.16b - Total Current Liabilities 1.23b) / Total Assets 6.21b |
| B: 0.07 (Retained Earnings 459.7m / Total Assets 6.21b) |
| C: 0.17 (EBIT TTM 996.2m / Avg Total Assets 5.85b) |
| D: 1.08 (Book Value of Equity 3.23b / Total Liabilities 2.99b) |
| Altman-Z'' Score: 2.45 = A |
Beneish M -2.42
| DSRI: 1.46 (Receivables 378.3m/236.6m, Revenue 2.22b/2.02b) |
| GMI: 1.03 (GM 32.46% / 33.45%) |
| AQI: 1.25 (AQ_t 0.06 / AQ_t-1 0.05) |
| SGI: 1.10 (Revenue 2.22b / 2.02b) |
| TATA: -0.02 (NI 570.5m - CFO 686.0m) / TA 6.21b) |
| Beneish M-Score: -2.42 (Cap -4..+1) = BBB |
What is the price of HBM shares?
As of March 24, 2026, the stock is trading at USD 18.85 with a total of 5,911,099 shares traded.
Over the past week, the price has changed by -10.83%, over one month by -27.64%, over three months by -5.44% and over the past year by +127.59%.
Over the past week, the price has changed by -10.83%, over one month by -27.64%, over three months by -5.44% and over the past year by +127.59%.
Is HBM a buy, sell or hold?
Hudbay Minerals has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy HBM.
- StrongBuy: 8
- Buy: 8
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HBM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.4 | 77.2% |
| Analysts Target Price | 33.4 | 77.2% |
HBM Fundamental Data Overview March 22, 2026
P/E Trailing = 12.9143
P/E Forward = 10.661
P/S = 3.2454
P/B = 2.2909
P/EG = 2.09
Revenue TTM = 2.22b USD
EBIT TTM = 996.2m USD
EBITDA TTM = 1.44b USD
Long Term Debt = 536.5m USD (from longTermDebt, last quarter)
Short Term Debt = 497.9m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 523.8m USD (from netDebt column, last quarter)
Enterprise Value = 7.70b USD (7.18b + Debt 1.09b - CCE 568.1m)
Interest Coverage Ratio = 13.44 (Ebit TTM 996.2m / Interest Expense TTM 74.1m)
EV/FCF = 35.87x (Enterprise Value 7.70b / FCF TTM 214.6m)
FCF Yield = 2.79% (FCF TTM 214.6m / Enterprise Value 7.70b)
FCF Margin = 9.69% (FCF TTM 214.6m / Revenue TTM 2.22b)
Net Margin = 25.75% (Net Income TTM 570.5m / Revenue TTM 2.22b)
Gross Margin = 32.46% ((Revenue TTM 2.22b - Cost of Revenue TTM 1.50b) / Revenue TTM)
Gross Margin QoQ = 33.37% (prev 18.83%)
Tobins Q-Ratio = 1.24 (Enterprise Value 7.70b / Total Assets 6.21b)
Interest Expense / Debt = 1.60% (Interest Expense 17.5m / Debt 1.09b)
Taxrate = 49.45% (129.1m / 261.1m)
NOPAT = 503.5m (EBIT 996.2m * (1 - 49.45%))
Current Ratio = 0.95 (Total Current Assets 1.16b / Total Current Liabilities 1.23b)
Debt / Equity = 0.34 (Debt 1.09b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 0.36 (Net Debt 523.8m / EBITDA 1.44b)
Debt / FCF = 2.44 (Net Debt 523.8m / FCF TTM 214.6m)
Total Stockholder Equity = 2.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.75% (Net Income 570.5m / Total Assets 6.21b)
RoE = 19.30% (Net Income TTM 570.5m / Total Stockholder Equity 2.96b)
RoCE = 28.53% (EBIT 996.2m / Capital Employed (Equity 2.96b + L.T.Debt 536.5m))
RoIC = 12.55% (NOPAT 503.5m / Invested Capital 4.01b)
WACC = 11.39% (E(7.18b)/V(8.27b) * Re(13.0%) + D(1.09b)/V(8.27b) * Rd(1.60%) * (1-Tc(0.49)))
Discount Rate = 13.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.04%
[DCF] Terminal Value 68.11% ; FCFF base≈257.1m ; Y1≈271.9m ; Y5≈322.9m
[DCF] Fair Price = 7.23 (EV 3.39b - Net Debt 523.8m = Equity 2.87b / Shares 396.9m; r=11.39% [WACC]; 5y FCF grow 6.36% → 3.0% )
EPS Correlation: 55.89 | EPS CAGR: 89.54% | SUE: -1.70 | # QB: 0
Revenue Correlation: 61.88 | Revenue CAGR: 19.44% | SUE: -0.59 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.42 | Chg7d=+0.004 | Chg30d=-0.001 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=1.68 | Chg7d=+0.006 | Chg30d=+0.045 | Revisions Net=+3 | Growth EPS=+150.9% | Growth Revenue=+29.8%
EPS next Year (2027-12-31): EPS=2.03 | Chg7d=+0.023 | Chg30d=+0.066 | Revisions Net=-2 | Growth EPS=+20.6% | Growth Revenue=+13.3%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 13.0% - Earnings Yield 7.7%)
[Growth] Growth Spread = +19.0% (Analyst 24.3% - Implied 5.3%)
P/E Forward = 10.661
P/S = 3.2454
P/B = 2.2909
P/EG = 2.09
Revenue TTM = 2.22b USD
EBIT TTM = 996.2m USD
EBITDA TTM = 1.44b USD
Long Term Debt = 536.5m USD (from longTermDebt, last quarter)
Short Term Debt = 497.9m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 523.8m USD (from netDebt column, last quarter)
Enterprise Value = 7.70b USD (7.18b + Debt 1.09b - CCE 568.1m)
Interest Coverage Ratio = 13.44 (Ebit TTM 996.2m / Interest Expense TTM 74.1m)
EV/FCF = 35.87x (Enterprise Value 7.70b / FCF TTM 214.6m)
FCF Yield = 2.79% (FCF TTM 214.6m / Enterprise Value 7.70b)
FCF Margin = 9.69% (FCF TTM 214.6m / Revenue TTM 2.22b)
Net Margin = 25.75% (Net Income TTM 570.5m / Revenue TTM 2.22b)
Gross Margin = 32.46% ((Revenue TTM 2.22b - Cost of Revenue TTM 1.50b) / Revenue TTM)
Gross Margin QoQ = 33.37% (prev 18.83%)
Tobins Q-Ratio = 1.24 (Enterprise Value 7.70b / Total Assets 6.21b)
Interest Expense / Debt = 1.60% (Interest Expense 17.5m / Debt 1.09b)
Taxrate = 49.45% (129.1m / 261.1m)
NOPAT = 503.5m (EBIT 996.2m * (1 - 49.45%))
Current Ratio = 0.95 (Total Current Assets 1.16b / Total Current Liabilities 1.23b)
Debt / Equity = 0.34 (Debt 1.09b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 0.36 (Net Debt 523.8m / EBITDA 1.44b)
Debt / FCF = 2.44 (Net Debt 523.8m / FCF TTM 214.6m)
Total Stockholder Equity = 2.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.75% (Net Income 570.5m / Total Assets 6.21b)
RoE = 19.30% (Net Income TTM 570.5m / Total Stockholder Equity 2.96b)
RoCE = 28.53% (EBIT 996.2m / Capital Employed (Equity 2.96b + L.T.Debt 536.5m))
RoIC = 12.55% (NOPAT 503.5m / Invested Capital 4.01b)
WACC = 11.39% (E(7.18b)/V(8.27b) * Re(13.0%) + D(1.09b)/V(8.27b) * Rd(1.60%) * (1-Tc(0.49)))
Discount Rate = 13.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.04%
[DCF] Terminal Value 68.11% ; FCFF base≈257.1m ; Y1≈271.9m ; Y5≈322.9m
[DCF] Fair Price = 7.23 (EV 3.39b - Net Debt 523.8m = Equity 2.87b / Shares 396.9m; r=11.39% [WACC]; 5y FCF grow 6.36% → 3.0% )
EPS Correlation: 55.89 | EPS CAGR: 89.54% | SUE: -1.70 | # QB: 0
Revenue Correlation: 61.88 | Revenue CAGR: 19.44% | SUE: -0.59 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.42 | Chg7d=+0.004 | Chg30d=-0.001 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=1.68 | Chg7d=+0.006 | Chg30d=+0.045 | Revisions Net=+3 | Growth EPS=+150.9% | Growth Revenue=+29.8%
EPS next Year (2027-12-31): EPS=2.03 | Chg7d=+0.023 | Chg30d=+0.066 | Revisions Net=-2 | Growth EPS=+20.6% | Growth Revenue=+13.3%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 13.0% - Earnings Yield 7.7%)
[Growth] Growth Spread = +19.0% (Analyst 24.3% - Implied 5.3%)